Manufacturing guide
Functional Beverage Co-Packing: What Founders Need Before Manufacturing
A functional beverage co-packer needs more than a product idea. Formula status, process requirements, package, batch size, ingredient plan, testing and shelf-life evidence determine whether a line can quote and run the product.
Short answer
A functional beverage co-packer manufactures and fills a beverage for another company. The right partner is not simply one with a beverage line: its process, fill technology, package handling, batch scale, quality system and sourcing model must fit the specific product.
Before a credible quote, expect to define the formula's status, intended safety/process route, container and closure, target batch or annual volume, ingredient responsibilities, tests, shelf-life plan and launch market. If those inputs are unresolved, request development and pilot scoping rather than treating the first price as a production quote.
Evidence guide: Published evidence — supported by the linked technical source. · Development guidance — a practical way to frame or test the product, not a universal specification. · Manufacturer-specific — depends on the selected process, equipment and commercial arrangement. · Product-specific validation — must be demonstrated with the actual formula, process, pack and market.
What a co-packer needs before quoting
| Brief item | Why it changes the quote or feasibility |
|---|---|
| Formula and ownership status | Determines whether transfer, reformulation or development is required |
| Ingredient forms and suppliers | Affects sourcing, handling, allergens and lead time |
| Product pH and physical system | Helps frame process and line suitability |
| Required process | Hot fill, cold fill, pasteurization, aseptic or other capability must match |
| Container, closure and size | Determines filler, seamer/capper, treatment and packing line |
| Carbonation | Requires compatible blending, filling and pressure-rated packaging |
| Batch/launch volume | Must fit tank, line and commercial minimums |
| Testing and shelf-life status | Defines unresolved development and release work |
| Target markets | Influences ingredients, labels, facility and documentation review |
An NDA may be appropriate before formula transfer, but confidentiality does not replace a structured technical brief.
Formula-ready, process-ready and production-ready are different
A bench formula may define ingredients and taste without being proven on a manufacturing process. A process-ready formula has been reviewed against the intended treatment and fill. A production-ready package also has approved specifications, artwork, sourcing and quality criteria.
Ask the co-packer to state which stage it expects at onboarding and which development services it provides. Some partners accept a concept and formulate it; others require a validated formula and process package. Misunderstanding this boundary creates schedule and ownership disputes.
Confirm the process and line fit
Discuss:
- blending and hydration capability;
- filtration, homogenization or deaeration where relevant;
- heat-treatment or aseptic system;
- carbonation;
- hot, ambient or cold fill;
- container/closure formats and size range;
- line speed and minimum efficient run;
- clean-in-place and allergen controls;
- post-fill cooling or tunnel treatment;
- coding, labelling and secondary packing.
Do not infer process capability from “beverage manufacturer” marketing. Confirm the actual line and the product conditions it can handle.
MOQ and batch size
MOQ can be driven by the smallest viable blend tank, line setup and cleaning time, ingredient case quantities, packaging print minimums, change parts and the co-packer's scheduling model. A quoted number can therefore mean different things: litres per batch, finished units per SKU, packaging units, or an annual commitment.
Ask what the MOQ includes and which inputs create it. A lower fill quantity may still require buying a larger quantity of printed cans, labels or closures. Do not publish one market-wide MOQ because plants and packaging arrangements differ materially.
Ingredient and packaging sourcing
Clarify responsibility for:
- approved ingredient suppliers and alternates;
- incoming specifications and testing;
- customer-supplied materials;
- minimum purchase quantities and residual inventory;
- containers, closures, labels, trays and cartons;
- artwork approval and print proofs;
- obsolescence when formula or artwork changes.
The lowest conversion fee can be outweighed by excess packaging inventory or unmanaged ingredient risk.
Pilot runs and scale-up
A pilot should answer defined questions, such as whether ingredients hydrate, the emulsion remains stable, heat exposure is acceptable, the product fills cleanly, the closure performs and the sensory target survives processing.
Confirm how representative the pilot equipment is, what quantity it produces, which tests are included, who owns the output and what criteria permit commercial scale-up. A kitchen sample followed directly by a commercial run shifts expensive uncertainty into production.
Testing, shelf life and release
Agree on:
- raw-material and finished-product specifications;
- process controls and records;
- microbiological, chemical, physical and sensory testing;
- external laboratory responsibilities;
- retain samples;
- shelf-life protocol and ownership;
- deviation and out-of-specification handling;
- certificate-of-analysis and batch-release responsibilities.
The exact plan depends on product and market. “Standard beverage testing” is not a sufficient answer for a novel active system.
Lead-time dependencies
A realistic schedule separates:
development → pilot → shelf-life evidence → packaging/tooling procurement → ingredient purchasing → production slot → testing/release → freight.
Packaging print, imported ingredients, line change parts, laboratory turnaround and production scheduling can each control the date. Ask for dependencies and decision deadlines, not only one headline lead time.
Questions founders should ask
- Which facility and line would run this product?
- Which formulation/process stage must we reach before transfer?
- What evidence supports the proposed safety process and shelf life?
- Which ingredients and packages can you source, and who owns excess inventory?
- What does your MOQ measure and what drives it?
- What happens during pilot, scale-up and the first commercial run?
- Which tests are included, outsourced or customer-owned?
- How are deviations, rework, loss and rejected materials handled?
- What certifications or market experience apply to the actual facility?
- Which assumptions could change price or timeline?
Use the RTD functional beverage guide to resolve formulation and process questions before partner selection.
Sources and evidence boundaries
- U.S. Food and Drug Administration, “Hazard Analysis and Risk-Based Preventive Controls for Human Food: Draft Guidance for Industry — Chapter 16: Acidified Foods.” Official guidance
- U.S. Food and Drug Administration, “Juice HACCP Regulator Training.” Official training material
- Vallath and Shanmugam, “Study on Model Plant Based Functional Beverage Emulsion (Non-Dairy) Using Ultrasound—A Physicochemical and Functional Characterization,” Ultrasonics Sonochemistry 88 (2022): 106070. Full text
- Almeida, Larentis and Ferraz, “Evaluation of the Stability of Concentrated Emulsions for Lemon Beverages Using Sequential Experimental Designs,” PLOS ONE 10 (2015): e0118690. Full text
The process examples show why product and hazard analysis drive manufacturing controls. MOQ, cost, capacity and lead time remain co-packer-, package- and project-specific; no market-wide figures are asserted here.